# Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor

> **NCT01212341** · PHASE1 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 18 (estimated)

## Conditions studied

- Malignant Lymphomas
- Solid Tumors

## Interventions

- **BIOLOGICAL:** Allogeneic NK cells

## Key facts

- **NCT ID:** NCT01212341
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2012-08
- **Final completion:** 2013-03
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2013-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01212341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01212341, "Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01212341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*